| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/24/2005 | US20050043300 Piperazine derivatives |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | US20050042676 Contacting sample with lysine selective agent to cap epsilon -amino group, digesting sample to produce peptide fragments, deactivating cleavage reagent, deblocking/deprotecting, then recovering fragments; solid phase synthesis; kits |
| 02/24/2005 | US20050042662 For tracing/imaging molecular transfer between cellular gap junctions |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534866A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | CA2500358A1 Probes for diseases in which amyloid accumulates, agents for staining amyloid, drugs for treatment and prophylaxis of diseases with accumulated amyloid, and probes for diagnosis of neurofibrillary tangles and agents for staining neurofibrillary tangles |
| 02/23/2005 | EP1507754A1 Alkoxy aryl beta-2 adrenergic receptor agonists |
| 02/23/2005 | EP1507532A2 Use of quinoline derivatives with anti-integrase effect and applications thereof |
| 02/23/2005 | EP1177177B1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585751A 喹啉化合物 Quinoline compound |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1585152A Current carrier transmtiting material with high-effect and balancing electronic cavity transmitting performance |
| 02/23/2005 | CN1583724A 7-(4, 4-dimethyl 3-aminomethylpentazane-1-radicle) substituted, quinoline carboxylic acid derivative and its preparation |
| 02/23/2005 | CN1190424C Quinoline-containing Alpha-ketoamide cysteine and serine protease inhibitors |
| 02/23/2005 | CN1190197C Use of cyanoquinolines for treating or inhibiting colonic polyps |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858627 For therapy of inflammatory, allergic, or proliferative conditions |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858621 Mbreast and prostate anticancer agents; viricides; alopecia |
| 02/17/2005 | WO2005014755A1 Alkynyl group-substituted condensed heterocyclic compound, method for producing same, and organic electroluminescent device using same |
| 02/17/2005 | WO2005014552A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 02/17/2005 | WO2005014529A1 2- adamantyl derivatives as p2x7 receptor antagonists. |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | WO2004078114A3 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists. |
| 02/17/2005 | WO2004016578A8 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 02/17/2005 | US20050038249 metal complexes used as prodrugs that may be activated under hypoxic conditions by enzymes or by radiotherapy for treatment of cancer |
| 02/17/2005 | US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 02/17/2005 | US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 02/17/2005 | US20050038070 Tetrahydroquinoline derivatives; modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer |
| 02/17/2005 | US20050038037 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 02/17/2005 | CA2532452A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506188A1 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1506000A1 Heterocyclicsulfonamide hepatitis c virus inhibitors |
| 02/16/2005 | EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
| 02/15/2005 | US6855824 Processes for preparing quinoline derivatives and intermediates thereof |
| 02/15/2005 | US6855726 Heterocyclic amides such as 3-(1-5-((2R,6S)-2,6-dimethyltetra-hydro-1(2H)-pyridinyl)pentyl-2-oxo-1,2 -dihydro-3-quinolinyl) benzenecarboximidamide, administered as anticoagulants or for prophylaxis of cardiovascular disorders |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/10/2005 | WO2005012579A2 Homodimeric cyanine dye dimer comprising aromatic, heteroaromatic, cyclic or heterocyclic linker moiety in nucleic acid reporter molecules |
| 02/10/2005 | WO2005012260A2 Synthetic method for the preparation of quinazolin-4-one derivative |
| 02/10/2005 | WO2005012251A1 Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same |
| 02/10/2005 | WO2005011601A2 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 02/10/2005 | WO2004110983A3 New benzamides as pparϒ modulators |
| 02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 02/10/2005 | US20050032848 Administering enzyme inhibitors of beta secretase, an enzyme responsible for the production of amyloid beta peptide by mediating the cleavage of amyloid precursor proteins; Alzheimer's disease; cognition activators; Down's syndrome; neurodegenerative diseases; other dementias of mixed origins |
| 02/10/2005 | US20050032835 Compositions and methods for inhibiting TGF-beta |
| 02/10/2005 | US20050032833 Fluorinated heterocyclic compounds and methods of synthesis |
| 02/10/2005 | US20050032832 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents |
| 02/10/2005 | US20050032831 Histone deacetylase inhibitors and methods of use thereof |
| 02/10/2005 | US20050032796 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | CA2533554A1 6-membered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 02/10/2005 | CA2531750A1 Synthetic method for the preparation of quinazolin-4-one derivative |
| 02/09/2005 | EP1503987A2 Preparation of an anhydrous quinoline-based cetp inhibitor by crystallization |
| 02/09/2005 | EP1503762A2 Novel crystalline forms of gatifloxacin |
| 02/09/2005 | EP1503759A2 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 02/09/2005 | EP1487795A4 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 02/09/2005 | EP1401446B1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
| 02/09/2005 | EP1387683B1 Novel salt and crystalline forms of (2r)-anti-5-3-(4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl)-2-hydroxypropoxy quinoline |
| 02/09/2005 | CN1578776A Heterocyclic retinoid compounds |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1576273A Process for Producing Aliprazo |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188121C Therapeutic substituted guanidines |
| 02/08/2005 | US6852862 Process for producing quinoline-3-carboxylic acid compound |
| 02/08/2005 | US6852712 Controlling cell differentiation; antiinflammatory agents |
| 02/08/2005 | CA2130754C Amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005009990A1 Aripiprazole crystalline forms |
| 02/03/2005 | WO2005009971A1 Quinolone derivative or salt thereof |
| 02/03/2005 | WO2005009970A1 An improved process for the preparation of gatifloxacin |
| 02/03/2005 | WO2005009969A1 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 02/03/2005 | WO2005009968A1 Quinoline derivates and their use in therapy |
| 02/03/2005 | WO2005009967A2 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/03/2005 | WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease |
| 02/03/2005 | US20050027120 Method for the synthesis of amides and related products from esters or ester-like compounds |
| 02/03/2005 | US20050027097 Multicolor; light emitting diodes; polyarylenevinylenes |
| 02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
| 02/03/2005 | US20050026947 1H-imidazo dimers |
| 02/03/2005 | US20050026942 Chemokine receptor binding heterocyclic compounds |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | US20050026785 Novel phenyl-propargylether derivatives |
| 02/03/2005 | CA2533626A1 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/03/2005 | CA2532154A1 Quinoline derivates and their use in therapy |
| 02/03/2005 | CA2530352A1 Quinolone derivative or salt thereof |
| 02/02/2005 | EP1501835A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/02/2005 | EP1501802A2 Process for the preparation of quinoline derivatives |
| 02/02/2005 | EP1501801A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/02/2005 | EP1286955B1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/02/2005 | CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |